Mens Health Topics

The On-Topic Netowork

Mens Health > Benign Prostatic Hyperplasia (Also Called Bph Or Benign Prostatic Hypertrophy.)

The following information is about Benign Prostatic Hyperplasia (Also Called Bph Or Benign Prostatic Hypertrophy.).

Benign Prostatic Hyperplasia (Also Called Bph Or Benign Prostatic Hypertrophy.) Defined

An enlargement of the prostate caused by disease or inflammation. It is not cancer, but its symptoms are often similar to those of prostate cancer.

This definition is in context to Mens Health. See more contextual defintions for Benign Prostatic Hyperplasia (Also Called Bph Or Benign Prostatic Hypertrophy.).


Navigation: [ 1 2 3 Next ]

Rapaflo for the Treatment of Symptoms Due to an Enlarged Prostate Gland Approved

Published October 12, 2008, 2:27 am, Kansas City InfoZine

The U.S. Food and Drug Administration today approved Rapaflo (silodosin) capsules for the treatment of symptoms due to benign prostatic hyperplasia (BPH), a condition also known as an enlarged prostate.

Full Story


Rapaflo Approved for Enlarged Prostate

Published October 10, 2008, 12:30 pm, MedicineNet.com

Title: Rapaflo Approved for Enlarged Prostate Category: Health News Created: 10/10/2008 2:00:00 AM Last Editorial Review: 10/10/2008

Full Story


Watson Receives US FDA Approval For RAPAFLO(TM) (silodosin) For The Treatment Of Benign Prostatic Hyperplasia (BPH)

Published October 10, 2008, 3:07 am, Medical News Today

Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved RAPAFLO(TM) (silodosin), the company's new alpha blocker for the treatment of the signs and symptoms of BPH.

Full Story


Urodynamix's Near Infrared Spectroscopy (NIRS) Technology In Urology Were Published In Two Journals

Published October 9, 2008, 12:08 pm, Medical News Today

Urodynamix Technologies Ltd. (TSX-V:URO) today announced that two peer-reviewed articles related to the application of its near infrared spectroscopy (NIRS) technology in urology were published in the October 2008 edition of the prestigious Canadian Journal of Urology with the launch of a special issue devoted to "Invention, Innovation and Evocation." In back-to-back articles, Andrew J.

Full Story


New fiber extends the use of the GreenLight Laser System beyond BPH

Published October 9, 2008, 7:00 am, Business Wire via Yahoo! Finance

MINNEAPOLIS----American Medical Systems, Inc. today announced the launch of its new GreenLight HPS EA Fiber intended for the treatment of bladder tumors and urethral strictures. According to Whitney Erickson, Vice-President and General Manager of the Men's Health Division at American Medical Systems, the new EA side-firing fiber is designed to extend the proven GreenLight technology beyond the ...

Full Story


Do Prostate Drugs Harm Bones?

Published October 8, 2008, 12:28 pm, MedicineNet.com

Title: Do Prostate Drugs Harm Bones? Category: Health News Created: 10/8/2008 Last Editorial Review: 10/8/2008

Full Story


Nymox Updates NX-1207 Product Development Activities

Published October 8, 2008, 8:51 am, Business Wire via Yahoo! Finance

HASBROUCK HEIGHTS, N.J.----Nymox Pharmaceutical Corporation provided today an update on development activities for the Company's NX-1207 drug for the treatment of benign prostatic hyperplasia or enlarged prostate, a common affliction of older men.

Full Story


Protox Announces Positive 12 Month Data from BPH Study

Published October 8, 2008, 8:50 am, T-Net British Columbia

Vancouver, BC, October 8, 2008--(T-Net)--Protox Therapeutics (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced positive 12 month data from its Phase 1 study of PRX302 in patients with benign prostatic hyperplasia (BPH), a common and bothersome urological condition among the aging male population.

Full Story


Health Discovery Corporation's New Prostate Cancer Test is Ready for Commercialization Following Successful Completion ...

Published October 8, 2008, 5:30 am, GlobeNewswire via Yahoo! Finance

SAVANNAH, Ga., Oct. 8, 2008 -- Health Discovery Corporation today announced that HDC's new gene-based molecular diagnostic test for prostate cancer has now successfully completed it's Phase III double-blind clinical trial and is now ready for commercialization to be used by physicians on their patients at risk of having prostate cancer.

Full Story


Watson Announces Positive Data for Its Investigational Oxybutynin Topical Gel for the Treatment of Overactive Bladder ...

Published October 8, 2008, 5:30 am, PR Newswire via Yahoo! Finance

Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that investigators presented clinical pharmacokinetic data on oxybutynin chloride topical gel , its investigational therapy for overactive bladder .

Full Story


Navigation: [ 1 2 3 Next ]

Are you looking for additional Mens Health > Benign Prostatic Hyperplasia (also Called Bph Or Benign Prostatic Hypertrophy.) news? Try our new "Benign Prostatic Hyperplasia (also Called Bph Or Benign Prostatic Hypertrophy.) News Focus" area.

Social bookmarks are not available at the moment.

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Benign Prostatic Hyperplasia (Also Called Bph Or Benign Prostatic Hypertrophy.). If you would like to find related tags we recommend Tag Patterns > Benign Prostatic Hyperplasia (Also Called Bph Or Benign Prostatic Hypertrophy.)

Off-site Benign Prostatic Hyperplasia (also Called Bph Or Benign Prostatic Hypertrophy.) Research Links

If you still need additional information on Benign Prostatic Hyperplasia (also Called Bph Or Benign Prostatic Hypertrophy.) then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Mens Health

If you know the Mens Health Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Mens-Health.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a